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Abstract
Background: Although many studies have evaluated the relationships between sleep duration and 
cardiovascular (CV) events/risk factors, longitudinal associations with time-dependent sleep duration 
have not been adequately assessed.
Methods: A retrospective, longitudinal study was conducted involving individuals aged 20 years or 
older that received annual health check-ups at St. Luke’s International Hospital from 2005 to 2010. 
Data collection included self-reported demographic, clinical and health habit information (including 
sleep duration; < 6, 6–7, 7–8, ≥ 8 h), baseline examinations, and laboratory measures for each year. We 
conducted mixed effects analyses to examine the associations between non-fatal CV events, risk factors, 
and time-dependent sleep duration longitudinally.
Results: Of the total of 31,830 participants enrolled, 70.1% of participants changed their sleep dura-
tion, and 365 participants experienced CV events during follow-up periods. Compared to those reporting 
7–8 h of sleep, those reporting less than 6 h of sleep were significantly more likely to experience non-fatal 
CV events (odds ratio [OR] 1.78; 95% confidence interval [CI] 1.03–3.07; p = 0.04), but other groups 
were not (OR 1.12; 95% CI 0.70–1.77; p = 0.64 for 6–7 h and OR 1.22; 95% CI 0.68–2.23; p = 0.50 
for ≥ 8 h). The shortest sleep duration was associated with a higher likelihood of obesity/overweight 
status (OR 1.49; 95% CI 1.32–1.69; p < 0.01).
Conclusions: Individuals reporting less than 6 h of sleep were significantly more likely to have non-
fatal CV events than those reporting 7–8 h of sleep. For the risk factors, short sleep duration was associ-
ated with obesity/overweight status. (Cardiol J 2018; 25, 2: 229–235)
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Introduction
Since the 1990’s, many studies have noted 
that people with short sleep durations have worse 
health outcomes [1–3]. Short sleep duration may 
be associated with mortality, cardiovascular (CV) 
events, and CV risk factors. Most of these studies 
indicate that getting less than 6 h of sleep per day 
is associated with higher incidences of these risk 
factors and events [2. 4, 5]. Some studies mention 
that longer sleep duration (more than 9 or 10 h) 
is also associated with higher incidences of these 
risk factors and events compared to adequate sleep 
duration (7–8 h) [6, 7]. Other studies had CV risk 
factors as the outcome measurements. The risk 
factors included hypertension [8, 9], diabetes (im-
paired glucose tolerance) [10–12], dyslipidemia 
(high cholesterol level) [13–15], metabolic syn-
drome [16, 17] and obesity (weight gain) [18–20]. 
Although the majority of prior studies suggested 
negative effects of short sleep duration on health 
outcomes, some could not demonstrate these ef-
fects [21–23]. As a result, the associations are still 
controversial.
Among these previous studies, most evaluated 
the relationships only by baseline sleep duration. 
For instance, one study evaluated the development 
of coronary heart disease with a one-time baseline 
sleep duration 10 years ago [3]. Very few studies 
have evaluated the relationships by time trends 
of sleep duration through longitudinal studies. In 
the limited number of longitudinal studies, sleep 
duration was repeatedly measured very few times. 
In addition, a previous study suggested that sleep 
duration variability is an independent risk factor for 
CV risk factors [24]. This means that most people 
may change their sleep habits. Therefore, longitu-
dinal studies with time-dependent sleep duration 
variables are needed to evaluate the effect of sleep 
duration on health more precisely.
The goal of this study is to investigate the re-
lationships between time-dependent sleep duration 
and CV events and risk factors using large-scale 
longitudinal data.
Methods
Study participants
This is a retrospective, longitudinal study 
with all subjects participating in an annual volun-
tary health check-up program at the Center for 
Preventive Medicine at St. Luke’s International 
Hospital in Tokyo, Japan from 2005 to 2010. All 
participants completed a questionnaire about de-
mographic information and health habits, including 
sleep duration and medical history, and underwent 
physical examinations and laboratory tests in an 
annual health check-up. The same information was 
obtained for each year during the study period. 
All participants included were 20 years or older 
in 2005. Individuals excluded had past medical 
histories of CV disease, including stroke. All data 
were extracted from electronic medical records. 
Ethical approval and informed consent
The St. Luke’s International Hospital Ethics 
Committee institutional review board approved 
this study.
Because this study was a retrospective cohort 
study, opt-out methodology wasapplied. Those 
that chose not to participate in the research were 
excluded.  
Measurement
Sleep duration. Sleep duration was measured 
by  participant response to a question about sleep 
duration. Participants filled the blank “Sleep dura-
tion: _ _ hours”. Participants were classified into 
four groups based on their answers: less than 6 h, 
6 h to less than 7 h, 7 h to less than 8 h, or more 
than 8 h [18]. The category of 7 h to less than 
8 h was considered as normal sleep duration and 
defined this group as the reference group in this 
study. Based on previous studies, a mean daily 
sleep time of less than 6 h was considered as 
a short sleep duration [25, 26].
Outcomes. Primary outcomes included non-
fatal CV events and the development of CV risk 
factors during follow-ups. Non-fatal CV events 
were determined based on a self-reported ques-
tionnaire at each health check-up. The develop-
ment of CV risk factors was defined as self-report-
ed and newly diagnosed hypertension, diabetes, 
dyslipidemia, and overweight/obesity status or 
abnormal related measurements on each factor. 
Participants with hypertension were defined as 
those with a self-reported history of hypertension, 
a measured systolic blood pressure of 140 mm Hg 
or greater, or a diastolic blood pressure of 
90 mm Hg or greater [27, 28]. In the same way, 
participants with diabetes mellitus were defined 
as those with a self-reported history of diabetes, 
a fasting blood sugar of 126 mg/dL or greater, or 
a hemoglobin A1c (HbA1c) of 6.5% or greater 
[29, 30]. Participants with dyslipidemia were de-
fined as those with a self-reported history, a low-
density lipoprotein cholesterol level of 140 mg/dL 
or greater, a high-density lipoprotein cholesterol 
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level of 40 mg/dL or less, or a triglyceride level of 
150 mg/dL or greater based on the criteria of the 
Japan Atherosclerosis Society [31]. Overweight/ 
/obesity status was defined as a measured body 
mass index of 25 kg/m2 or higher based on the 
World Health Organization criteria for Asians [32]. 
Covariates. Participants were asked about 
the types and amount of alcohol they consumed in 
a week. Calculated average daily alcohol consump-
tion was based on the questionnaire and partici-
pants were classified into two categories, excessive 
alcohol consumption vs. non-excessive alcohol 
consumption. Excessive alcohol consumption was 
defined as drinking more than 28 g/day (2 drinks) 
for males and 14 g/day (1 drink) for females based 
on criteria from the Centers for Disease Control 
and Prevention [33].
Participants were also asked about cigarette 
smoking and average number of packs of cigarettes 
smoked daily. They were classified as current 
smoker, former smoker, or never a smoker. 
They were also asked about exercise habits 
in the form of how many times they exercised per 
week. Participants were classified as those who 
exercised regularly (at least 3 times a week) or 
those who exercised less than 3 times per week. 
Participants were asked about their occupations 
as well. Participant occupations were divided into 
three categories: unemployed, non-physical job and 
physical job, based on the answers from the self-
reported questionnaire. Marital status was divided 
into two categories: married and unmarried.
Statistical methods
Cross-sectional analyses were conducted on 
participant characteristics at baseline in 2005. 
c2 tests were applied to categorical variables, 
and analysis of variance (ANOVA) was used for 
continuous variables. Then, longitudinal analyses 
were performed with the data from 2006 to 2010 
to investigate the longitudinal association between 
sleep duration and CV events and risk factors. Ad-
justed odds ratios (OR) for binominal outcomes of 
future non-fatal CV events and risk factors were 
obtained with the model of the binominal family 
with the logit link function. To account for repeated 
observations within participants and random ef-
fects of observations, a mixed effects model were 
applied with an unstructured working correlation. 
To account for changes in sleep duration over time, 
sleep durations were designated differently as 
time-dependent variables in longitudinal analyses. 
All analyses were performed in 2012 using 
SPSS 19.0J statistical software (IBM Japan, Tokyo, 
Japan) and STATA 14 (STATA Corp., College Sta-
tion, TX, USA).
Results
In 2005, 40,035 participants received annual 
health check-ups. Among them, 796 were excluded 
due to past CV events. Participant characteris-
tics at baseline are shown in Table 1. In terms of 
participant demographic information, those that 
reported less than 6 h of sleep at baseline tended 
to be younger and have more physical jobs but typi-
cally smoked cigarettes frequently, had infrequent 
exercise habits and were unmarried. In terms 
of clinical factors, those reporting shorter sleep 
duration tended to have less comorbidities and 
clinical measurements (95% confidence interval 
[CI] 0.66–0.85). 
In longitudinal analyses, 31,830 (81.1%) par-
ticipants attended health check-ups at least one 
time during the study periods. Throughout the 
follow-up periods, 70.1% of individuals changed 
their sleep duration category from baseline. How-
ever, the proportion of each sleep duration category 
were stable over the study period (Fig. 1). Three 
hundred sixty-five (1.1%) participants developed 
CV events. Longitudinal analyses revealed that 
those reporting less than 6 h sleep duration had 
a significantly higher OR of 1.78 (95% CI 1.03–3.07) 
for non-fatal CV events compared to those report-
ing 7–8 h sleep duration. In terms of clinical factors, 
those with short sleep duration (less than 6 h) were 
significantly overweight/obese (OR 1.49, 95% CI 
1.32–1.69) but had lower rates of development for 
hypertension (OR 0.75, 95% CI 0.66–0.85) and 
dyslipidemia (OR 0.90, 95% CI 0.81–0.98) (Table 2). 
Table 3 shows the longitudinal relationships be-
tween clinical measurements and time-dependent 
sleep duration. These results were consistent 
with those for clinical factors, except for HbA1c 
(b coefficient: 0.01, 95% CI 0.01–0.02). In terms 
of longer sleep duration than 8 h, participants had 
no significant findings for all outcomes.
Discussion
In our longitudinal study, time-dependent 
short sleep duration was associated with the de-
velopment of CV events and obesity/overweight 
status, which is consistent with the majority of 
previous cross-sectional and cohort studies. In 
contrast, time-dependent short sleep duration had 
favorable associations with diabetes and dyslipi-
demia, which is inconsistent with previous studies. 
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The associations between sleep duration and CV 
events or risk factors are still controversial, espe-
cially for specific populations such as the elderly 
[34] or obese people [35]. Although a conclusion 
was not reached, adequate sleep duration would be 
clinically favorable compared to extremely short or 
long sleep duration. 
In terms of CV events, obesity/overweight 
status and diabetes findings in our study were 
consistent with the majority of previous studies, 
even accounting for time-dependent sleep duration. 
Many previous studies discuss the mechanisms for 
the association between short sleep duration, CV 
events, and obesity. These may manifest through 
biochemical causes [36], social-behavioral causes 
[37], and/or CV risk-associated diseases. One 
Figure 1. Trends of the sleep duration category over 
5 years.
Table 1. Participant characteristics by sleep duration at baseline (n = 39,239).
Sleep category
< 6 h
(24.9%)
6–7 h
(40.1%)
7–8 h
(25.8%)
> 8 h
(8.4%)
P
Demographics:
Age [year] 43.7 ± 10.8 46.9 ± 11.5) 50.2 ± 12.6) 53.5 ± 14.3) < 0.01
Male 51.1 49.1 50.1 51.2 < 0.01
Social habit and status:
Excessive alcohol use* 17.2% 16.4% 16.6% 19.8% 0.04
Current smoker 22.2% 18.9% 16.9% 18.2% < 0.01
Exercise ≥ 3 times a week 19.5% 22.9% 28.2% 32.4% < 0.01
Physical job 16.7% 13.7% 12.6% 13.9% < 0.01
Married 62.7% 70.4% 76.4% 78.9% < 0.01
Clinical factors:
Hypertension† 12.6% 14.8% 19.6% 24.4% < 0.01
Diabetes‡ 1.3% 1.6% 1.7% 2.6% 0.01
Dyslipidemia§ 2.9% 3.5% 4.6% 6% < 0.01
Clinical measurements:
Body mass index 22.6 ± 3.5 22.4 ± 3.3 22.3 ± 3.1 22.2 ± 3.2 < 0.01
Systolic blood pressure 115.9 ± 16.6 116.8 ± 17.2 119.1 ± 18.1 121.3 ± 19.0 < 0.01
Diastolic blood pressure 72.1 ± 10.9 72.7 ± 11.2 74.0 ± 11.4 75.0 ± 11.6 < 0.01
Fasting blood sugar 99.0 ± 15.7 99.3 ± 15.6 100.0 ± 15.7 101.0 ± 17.8 < 0.01
Hemoglobin A1c 5.6 ± 0.6 5.1 ± 0.6 5.1 ± 0.6 5.2 ± 0.6 < 0.01
Total cholesterol 198.9 ± 34.3 202.2 ± 34.6 204.8 ± 33.9 207.4 ± 35.2 0.1
LDL cholesterol 114.2 ± 30.3 116.2 ± 30.3 117.7 ± 29.7 119.2 ± 30.8 0.11
HDL cholesterol 62.2 ± 15.9 62.4 ± 15.8 62.2 ± 15.8 61.8 ± 15.8 0.95
Triglycerides 98.9 ± 82.0 101.3 ± 86.1 102.6 ± 75.6 108.7 ± 88.7 < 0.01
HDL — high-density lipoprotein; LDL — low-density lipoprotein
*Excessive alcohol use indicates consuming more than 28 g of alcohol per day for males and 14 g per day for females
†Hypertension indicates those with a history of hypertension or abnormality at baseline
‡Diabetes mellitus indicates those with a history of diabetes mellitus or abnormality in 2005
§Dyslipidemia indicates those with a history of dyslipidemia or abnormality in 2005
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previous study discussed the possible mechanisms 
for developing diabetes in association with short 
sleep duration [38]. According to the study, short 
sleep duration stimulates adipocytes and increases 
circulating adipokine levels. Another study sug-
gested that short sleep duration may decrease 
insulin sensitivity [39]. As a result, short sleepers 
are susceptible to the development of diabetes. 
Therefore, the present findings that sleep dura-
tion less than 6 h had negative effects on health 
outcomes were supported.
The reasons why some findings, such as the 
results on hypertension and dyslipidemia, con-
tradicted previous studies are unclear. The main 
difference between our study and other previous 
studies is that changes in sleep duration wereac-
counted for over time within individuals. As men-
tioned above, approximately 70% of participants 
changed their sleep duration from baseline during 
the study period. This adaptation and other po-
tential confounders may explain the differences in 
results between this study and other predominant 
studies. For instance, individuals with obstructive 
sleep apnea syndrome or insomnia described as 
having short sleep duration may have been treated 
for these disorders. As a result, hypertension, 
which is major complication of these disorders, 
may be resolved. In addition, there are several 
possible factors that may be prompted by dynamic 
social circumstances and could be associated with 
Table 2. Longitudinal association between time-dependent sleep duration and cardiovascular events/ 
/risk factors.
Adjusted odds ratios* (95% confidence interval)
Cardiovascular 
event
Hypertension† Diabetes  
mellitus‡
Dyslipidemia§ Overweight/ 
/obesity status**
Less than 6 h 1.78 (1.03–3.07) 0.75 (0.66–0.85) 1.18 (0.95–1.46) 0.90 (0.81–0.98) 1.49 (1.32–1.69)
6–7 h 1.12 (0.70–1.77) 0.87 (0.79–0.97) 1.11 (0.93–1.32) 0.95 (0.87–1.03) 1.19 (1.07–1.32)
7–8 h Reference
More than 8 h 1.22 (0.68–2.23) 1.06 (0.92–1.24) 1.10 (0.86–1.40) 0.96 (0.85–1.09) 0.90 (0.76–1.07)
*Adjusted odds ratios: Models were adjusted for age, gender, occupation, health habits, marital status, calorie intake and time variables. Sleep 
duration was treated as the time-dependent variable. The numbers in bold indicate statistical significance with a p-value less than 0.05
†Hypertension indicates those with a history of hypertension or abnormality at follow-ups
‡Diabetes mellitus indicates those with a history of diabetes mellitus or abnormality at follow-ups
§Dyslipidemia indicates those with a history of dyslipidemia or abnormality at follow-ups
**Overweight/obesity status indicates a body mass index higher than 25 kg/m2 based on World Health Organization criteria for Asians at 
follow-ups
Table 3. Longitudinal association between time-dependent sleep duration and cardiovascular-related 
factors.
Adjusted b-coefficients* (95% confidence interval)
SBP DBP FBS HbA1c TC LDL-C HDL-C TG
Less than  
6 h
–0.45  
(–0.72  
to –0.18)
–0.29  
(–0.46  
to –0.12)
0.23  
(–0.02  
to 0.47)
0.01  
(0.01  
to 0.02)
–0.18  
(–0.74  
to 0.38)
–0.22  
(–0.70  
to 0.26)
0.66  
(0.46  
to 0.87)
–2.42  
(–3.79 
to –1.06)
6–7 h –0.31  
(–0.53  
to –0.09)
–0.09  
(–0.23  
to 0.05)
0.05  
(–0.14  
to 0.25)
0.01  
(0.01  
to 0.01)
0.15  
(–0.30  
to 0.60)
0.03  
(–0.36  
to 0.41)
0.36  
(0.19  
to 0.52)
–0.83  
(–1.95  
to 0.29)
7–8 h Reference
More than  
8 h
0.21  
(–0.13  
to 0.57)
0.02  
(–0.20  
to 0.23)
0.03  
(–0.28  
to 0.33)
0.01  
(–0.01  
to 0.01)
0.30  
(–0.40  
to 1.01)
0.09  
(–0.52  
to 0.69)
–0.08  
(–0.34  
to 0.17)
1.62  
(–0.13  
to 3.37)
*Adjusted b-coefficients: Models were adjusted for age, gender, occupation, health habits, marital status, calorie intake, treatment status  
outcomes and time variables. Sleep duration was treated as a time-dependent variable; The numbers in bold indicate statistical significance 
with a p-value less than 0.05
DBP — diastolic blood pressure; FBS — fasting blood sugar; HbA1c — hemoglobin A1c; HDL-C — high-density lipoprotein cholesterol;  
LDL-C — low-density lipoprotein cholesterol; SBP — systolic blood pressure; TG — triglycerides; TC — total cholesterol
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the results. Social stress, sleep disturbance from 
night-shift working or lifestyle changes, reduced 
physical activity related to transportation or hor-
monal disorders are all examples of factors that 
may be related to the results. Furthermore, the 
fact that the category of those sleeping less than 
6 h included younger participants may explain the 
unexpected results.
Limitations of the study
There are some limitations in this study. First, 
some of the participants were not followed-up. 
Although the follow-up rate was more than 80%, 
those that were not followed may bias the results. 
However, considering the retrospective nature of 
the study, it is believed that a greater than 80% 
follow-up rate is still acceptable and therefore 
the bias is limited. In addition, they may be more 
interested in their health than the general popula-
tion, because this is a completely voluntary health 
check. This may induce selection bias. Second, our 
data did not contain certain confounders such as 
quality of sleep, history of insomnia or sleep apnea 
syndrome. In addition, some information was lack-
ing which related to CV events/risk factors, such as 
pathology and treatment status. These confound-
ers may have influenced the results. Self-reported 
sleep duration and clinical outcomes may induce 
recall bias. Finally, quality of sleep may also be 
important for precise evaluations of the discussed 
associations. Further studies, which are prospec-
tive, have objective measurement for sleep dura-
tion, and have information about quality of sleep are 
needed to evaluate the longitudinal associations.
Conclusions
In this study, significant associations between 
short sleep duration and CV events and obesity/ 
/overweight status were observed, even in con-
sideration of sleep duration as a time-dependent 
variable. Relationships between sleep duration 
and other risk factors, including hypertension and 
dyslipidemia, are still controversial.
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